Back to Trials
NCT03759717Recruiting

Molecular and Cellular Characterization of Skull Base Tumors

University of Pittsburgh

Start Date

10/3/2018

Completion Date

10/3/2028

Summary

The purpose of the study is to analyze biological samples and genetic material for basic science research investigating the molecular and cellular characterization of skull base tumors.

Detailed Description

The overall goal of this proposal is to determine new molecular and cellular features that define tumor subtypes that are clinically actionable, may drive important changes in patient management, and/or elucidate novel chemotherapeutic options. Skull base tumors are currently diagnosed based on histopathologic criteria, on which post-operative management is based. However, the investigators hypothesize that each tumor type (eg. chordoma or chondrosarcoma) will have molecular and/or cellular subcategories that will redefine how to categorize and diagnose patients, predict clinical outcome, and optimally design a patient-specific management strategy. In addition, we aim to catalogue changes that occur after treatment after surgical resection, chemotherapy, and/or radiation by comparing primary and recurrent tumors.

Eligibility Criteria

Age Range: No minimum to No maximum

Inclusion Criteria: * Diagnosis of a skull base tumor Exclusion Criteria: * Insufficient tumor sample at time of resection

Interventions

OTHER

Observation

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Skull Base NeoplasmCellular Pathology

Locations

University of Pittsburgh Medical Center

Pittsburgh, Pennsylvania 15213

United States